Medpace Holdings (MEDP) Common Equity (2015 - 2026)

Medpace Holdings (MEDP) has reported Common Equity for 12 consecutive years, with $433.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 151.73% year-over-year to $433.9 million; the trailing twelve-month figure through Jun 2026 stood at $433.9 million (up 151.73% YoY), and the FY2025 full-year result was $459.1 million, down 44.39% from the prior year.
• Common Equity retreated to $433.9 million in Q2 2026 per MEDP's latest filing, from $598.3 million in the prior quarter.
• Across five years, Common Equity topped out at $881.4 million in Q3 2024 and bottomed at $172.4 million in Q2 2025.
• Historically, Common Equity has averaged $504.8 million across 5 years, with a median of $465.0 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Common Equity tumbled 77.43% in 2025, then soared 151.73% in 2026.
• Over 5 years, Common Equity stood at $386.4 million in 2022, then surged by 44.66% to $558.9 million in 2023, then surged by 47.7% to $825.5 million in 2024, then tumbled by 44.39% to $459.1 million in 2025, then decreased by 5.49% to $433.9 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $433.9 million, $598.3 million, and $459.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.